Abstract
Helicobacter pylori is now recognized as the primary etiological factor associated with gastritis, peptic ulcer disease and gastric cancers. Fluoroquinolones have been shown to be active against H. pylori. For develop new anti-H. pylori agents, we have investigated the SAR of a series of N-(phenethyl)piperazinyl quinolones for their antimicrobial activity against H. pylori. The anti-H. pylori activity of synthesized compounds along with commercially available anti-H. pylori agents such as metronidazole, and parent quinolones was evaluated by the disc diffusion bioassay. The results indicated that the potency and anti-H. pylori activity profile of the quinolones is highly dependent on the type of substituent at N-1 and the structure of phenethyl unit on piperazine ring. Most compounds containing a cyclopropyl at N-1 exhibited good activity against H. pylori strains. Among them, ciprofloxacin derivative 13 containing 2-methoxyimino-2-(2- chlorophenyl)ethyl moiety was the most active compound.
Keywords: Fluoroquinolones, 7-piperazinyl quinolones, Helicobacter pylori, antibacterial activity
Medicinal Chemistry
Title: Structure-Activity Relationship Study of a Series of N-Substituted Piperazinyl-Fluoroquinolones as Anti-Helicobacter pylori Agents
Volume: 4 Issue: 5
Author(s): A. Foroumadi, M. Safavi, S. Emami, F. Siavoshi, S. Najjari, F. Safari and A. Shafiee
Affiliation:
Keywords: Fluoroquinolones, 7-piperazinyl quinolones, Helicobacter pylori, antibacterial activity
Abstract: Helicobacter pylori is now recognized as the primary etiological factor associated with gastritis, peptic ulcer disease and gastric cancers. Fluoroquinolones have been shown to be active against H. pylori. For develop new anti-H. pylori agents, we have investigated the SAR of a series of N-(phenethyl)piperazinyl quinolones for their antimicrobial activity against H. pylori. The anti-H. pylori activity of synthesized compounds along with commercially available anti-H. pylori agents such as metronidazole, and parent quinolones was evaluated by the disc diffusion bioassay. The results indicated that the potency and anti-H. pylori activity profile of the quinolones is highly dependent on the type of substituent at N-1 and the structure of phenethyl unit on piperazine ring. Most compounds containing a cyclopropyl at N-1 exhibited good activity against H. pylori strains. Among them, ciprofloxacin derivative 13 containing 2-methoxyimino-2-(2- chlorophenyl)ethyl moiety was the most active compound.
Export Options
About this article
Cite this article as:
Foroumadi A., Safavi M., Emami S., Siavoshi F., Najjari S., Safari F. and Shafiee A., Structure-Activity Relationship Study of a Series of N-Substituted Piperazinyl-Fluoroquinolones as Anti-Helicobacter pylori Agents, Medicinal Chemistry 2008; 4 (5) . https://dx.doi.org/10.2174/157340608785700162
DOI https://dx.doi.org/10.2174/157340608785700162 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Anti-Inflammatory and Antioxidant Properties of Piper Species: A Perspective from Screening to Molecular Mechanisms
Current Topics in Medicinal Chemistry Salmonella as Live Trojan Horse for Vaccine Development and Cancer Gene Therapy
Current Gene Therapy Metastasis Suppressors: Basic and Translational Advances
Current Pharmaceutical Biotechnology Functional Genomics- and Network-driven Systems Biology Approaches for Pharmacogenomics and Toxicogenomics
Current Drug Metabolism Interventions Against Sarcopenia in Older Persons
Current Pharmaceutical Design MicroRNAs: A Critical Regulator and a Promising Therapeutic and Diagnostic Molecule for Diabetic Cardiomyopathy
Current Gene Therapy Acetaminophen (Paracetamol) and Injury in the Cardiovascular System
Vascular Disease Prevention (Discontinued) Angiotensin Converting Enzyme Inhibitory Peptides Derived from Food Proteins: Biochemistry, Bioactivity and Production
Current Pharmaceutical Design Gambogic Acid is a Novel Anti-cancer Agent that Inhibits Cell Proliferation, Angiogenesis and Metastasis
Anti-Cancer Agents in Medicinal Chemistry Proteomics Annotation of Lipid Rafts Modified by Virus Infection
Combinatorial Chemistry & High Throughput Screening Ganoderma lucidum (Ling-zhi): The Impact of Chemistry on Biological Activity in Cancer
Current Bioactive Compounds New Approaches With Natural Product Drugs for Overcoming Multidrug Resistance in Cancer
Current Pharmaceutical Design Mucosal Repair and COX-2 Inhibition
Current Pharmaceutical Design Local Gene Delivery for Cancer Therapy
Current Gene Therapy Targeting Invasion Induction as a Therapeutic Strategy for the Treatment of Cancer
Current Cancer Drug Targets Recent Clinical Aspects of Eating Disorders
Reviews on Recent Clinical Trials Anti-Carcinogenic Effects of Carnosol-An Updated Review
Current Drug Discovery Technologies The Bioactive Acidic Serine- and Aspartate-Rich Motif Peptide
Current Protein & Peptide Science Omega-3 Fatty Acids and their Role in Central Nervous System - A Review
Current Medicinal Chemistry Metabolomics as a Functional Tool in Screening Gastro Intestinal Diseases: Where are we in High Throughput Screening?
Combinatorial Chemistry & High Throughput Screening